Liraglutide for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jan 2012: Trial registered, NCT01508949

The trials

NCT01508949: Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

State
Completed
Phase
Phase 2
People
35 taking part
Started
Jun 2001
Primary completion
Mar 2002
Arms
NNC 90-1170
Results
None posted
  1. 12 Jan 2012: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Saxenda, Victoza, XULTOPHY 100/3.6 COMPONENT LIRAGLUTIDE.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.